History Taking – Risk Stratification
In assessing children with acute illness or a history of decreased urine output, you must assess whether they are at increased risk of AKI. Guidelines from the British Association of Paediatric Nephrologists (BAPN) identify two groups who are at increased risk of AKI:
Children in high-risk groups OR high-risk scenarios are at risk of AKI and should have a serum creatinine according to BAPN guidelines.
Table 1: High risk groups for Paediatric AKI
High risk groups | Examples |
Nephro-urological, cardiac or liver disease | Henoch-Schönlein Purpura (HSP) with renal involvement, Nephritic Syndrome, Polycystic Kidneys, Heart failure, Kidney/Liver Transplant |
Malignancy and/ or a bone marrow transplant | Acute Lymphoblastic Leukaemia (ALL) |
Dependence on others for access to fluids | Neonates, infants, children with severe neurodisability |
History of taking medication that may adversely affect renal function | ● ACE Inhibitors/Angiotensin 2 receptor blockers – e.g. enalapril, captopril, losartan
● NSAIDs – e.g. ibuprofen ● Aminoglycoside antibiotics – e.g. gentamicin ● calcineurin inhibitors – e.g. tacrolimus for children post transplantation |
Table 2: High risk scenarios for Paediatric AKI
High risk scenarios |
History of reduced urine output**(<0.5 ml/kg/hour for 8 hours) |
Sepsis |
Hypoperfusion or dehydration |
History of exposure to drugs or toxin that may adversely affect renal function |
Renal disease or urinary tract obstruction |
Major surgery |
AKI Risk Stratification and clinical judgement
For a child identified as being at increased risk of AKI using the BAPN guidelines, clinical judgement can be used to determine whether serum creatinine testing is needed. In particular:
Pitfalls